Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis. [electronic resource]
Producer: 20081001Description: 169-80 p. digitalISSN:- 1449-1907
- Animals
- Anti-Inflammatory Agents -- pharmacology
- Antibodies, Monoclonal -- pharmacology
- Apoptosis -- drug effects
- Benzenesulfonates
- Blotting, Western
- Colitis -- chemically induced
- Disease Models, Animal
- Enterocytes -- drug effects
- Etanercept
- Fas Ligand Protein -- metabolism
- Immunoglobulin G -- pharmacology
- Immunohistochemistry
- In Situ Nick-End Labeling
- Infliximab
- Male
- Mice
- Mice, Knockout
- Proto-Oncogene Proteins c-bcl-2 -- metabolism
- Receptors, Tumor Necrosis Factor
- Receptors, Tumor Necrosis Factor, Type I -- genetics
- Tumor Necrosis Factor-alpha -- blood
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.